Richard Zhao

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy
    Hailiu Yang
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA
    Cell Biosci 2:32. 2012
  2. ncbi APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication
    Lin Li
    Department of Pathology, University of Maryland, 10 South Pine Street, MSTF700A, Baltimore, MD 21201, USA
    Retrovirology 5:72. 2008
  3. ncbi Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R
    Ge Li
    Department of Pathology, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
    Retrovirology 7:59. 2010
  4. ncbi Vpr-host interactions during HIV-1 viral life cycle
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Neuroimmune Pharmacol 6:216-29. 2011
  5. ncbi Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
    PLoS ONE 5:e11466. 2010
  6. ncbi [Enhanced protein production of Vif and APOBEC3G by HIV-1 Vpr]
    Lin Li
    Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 22:39-41. 2008
  7. ncbi From single cell gene-based diagnostics to diagnostic genomics: current applications and future perspectives
    Richard Zhao
    Division Head of Molecular Pathology, Department of Pathology, University of Maryland Medical Center, Baltimore, MD 21201 1192, USA
    Clin Lab Sci 18:254-62. 2005
  8. ncbi Viral infections and cell cycle G2/M regulation
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 2120, USA
    Cell Res 15:143-9. 2005
  9. ncbi Molecular-based laboratory testing and monitoring for human immunodeficiency virus infections
    Niel Constantine
    Clinical Immunology Laboratory, University of Maryland Medical Center, Baltimore, MD 21201-1192, USA
    Clin Lab Sci 18:263-70. 2005
  10. ncbi HIV-1 viral protein R (Vpr) & host cellular responses
    Richard Yuqi Zhao
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, MSTF 600, Baltimore, MD 21201, USA
    Indian J Med Res 121:270-86. 2005

Research Grants

  1. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2007
  2. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2006
  3. Cell Cycle G2/M Pathway Modulated by Viral Protein R
    Richard Zhao; Fiscal Year: 2006
  4. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2003

Collaborators

Detail Information

Publications12

  1. ncbi Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy
    Hailiu Yang
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA
    Cell Biosci 2:32. 2012
    ....
  2. ncbi APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication
    Lin Li
    Department of Pathology, University of Maryland, 10 South Pine Street, MSTF700A, Baltimore, MD 21201, USA
    Retrovirology 5:72. 2008
    ..In this pilot study, we tested whether APOBEC3G, when it is fused with UBA2, can resist Vif-mediated proteasomal degradation and further inhibit HIV-1 infection...
  3. ncbi Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R
    Ge Li
    Department of Pathology, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
    Retrovirology 7:59. 2010
    ..Even though Vpr-induced G2 arrest has been studied extensively, how Vpr triggers G2 arrest remains elusive...
  4. ncbi Vpr-host interactions during HIV-1 viral life cycle
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Neuroimmune Pharmacol 6:216-29. 2011
    ....
  5. ncbi Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
    PLoS ONE 5:e11466. 2010
    ..Therefore, Vpr could possibly be used as a supplemental viral therapeutic agent for selective inhibition of tumor growth in anti-cancer therapy especially when other therapies stop working...
  6. ncbi [Enhanced protein production of Vif and APOBEC3G by HIV-1 Vpr]
    Lin Li
    Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 22:39-41. 2008
    ..Goal of this study was to test the potential regulatory effects of Vpr on Vif and Vif-mediated degradation of APOBEC3G...
  7. ncbi From single cell gene-based diagnostics to diagnostic genomics: current applications and future perspectives
    Richard Zhao
    Division Head of Molecular Pathology, Department of Pathology, University of Maryland Medical Center, Baltimore, MD 21201 1192, USA
    Clin Lab Sci 18:254-62. 2005
    ..New technologies that could potentially be used in future gene-based diagnosis are introduced...
  8. ncbi Viral infections and cell cycle G2/M regulation
    Richard Y Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 2120, USA
    Cell Res 15:143-9. 2005
    ....
  9. ncbi Molecular-based laboratory testing and monitoring for human immunodeficiency virus infections
    Niel Constantine
    Clinical Immunology Laboratory, University of Maryland Medical Center, Baltimore, MD 21201-1192, USA
    Clin Lab Sci 18:263-70. 2005
    ..Newer approaches that could be used in future HIV testing are also introduced...
  10. ncbi HIV-1 viral protein R (Vpr) & host cellular responses
    Richard Yuqi Zhao
    Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, MSTF 600, Baltimore, MD 21201, USA
    Indian J Med Res 121:270-86. 2005
    ..Strategies with potential application for future antiviral therapies directed at suppressing Vpr activities are described...
  11. ncbi Anti-Vpr activity of a yeast chaperone protein
    Zsigmond Benko
    Children's Memorial Institute for Education and Research, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, 2430 N. Halsted St. #218, Chicago, IL 60614, USA
    J Virol 78:11016-29. 2004
    ..This finding could potentially provide a new approach to studying the contribution of Vpr to viral pathogenesis and to reducing Vpr-mediated detrimental effects in HIV-infected patients...
  12. ncbi Fission yeast homologue of Tip41-like proteins regulates type 2A phosphatases and responses to nitrogen sources
    Csaba Fenyvuesvolgyi
    Children s Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA
    Biochim Biophys Acta 1746:155-62. 2005
    ..These results suggest that fission yeast Tip41 plays a role in cellular responses to nitrogen nutrient conditions at least partly through regulation of type 2A phosphatase activity...

Research Grants11

  1. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2007
    ..abstract_text> ..
  2. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2006
    ..abstract_text> ..
  3. Cell Cycle G2/M Pathway Modulated by Viral Protein R
    Richard Zhao; Fiscal Year: 2006
    ..These proposed studies will provide a comprehensive framework for this new cell cycle control pathway and provide insights into fundamental aspects of this new G2/M surveillance system of eukaryotic cells. ..
  4. Effect of HIV-1 Vpr on Basic Cellular Functions (II)
    Richard Zhao; Fiscal Year: 2003
    ..abstract_text> ..